Will China’s healthcare crackdown be the magic pill for the medical system’s woes?
- Beijing’s anti-corruption campaign has tried to bring in reforms similar to the Sanming model, targeting hospitals, drug companies and insurance funds
- But many experts question whether the crackdown has gone far enough to fix the systemic problems

The magical pill was called the “Sanming model” – a reformed approach to medical care pioneered about a decade ago in Sanming, Fujian province. It was so successful that it has since been trumpeted as a national best for the rest of the country to follow.
Rent-seeking became rampant, as pharmaceutical sales teams offered generous kickbacks to doctors and hospital administrators, who in turn spent lavishly on expensive drugs and equipment. Bribes – often in millions of yuan – were disguised as academic conference sponsorship or lecture fees, as well as extravagant junkets.
The Sanming model aimed to remove the cancers in the system. It implemented centralised procurement, set bulk purchases of drugs at fixed prices, introduced pay ceilings for doctors and linked the salaries of hospital management with how much they cut costs.